Physician profile
Nataly Rincon
NPI 1972295160
$1,776.88
in general payments reported to CMS, 2019-2025
17 companies · $1,755 in 2025
The $1,755 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $21.53 · 2025: $1,755.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,777.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,776.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $294.84 | 2025 | Tezspire, Airsupra, Fasenra |
| Novartis Pharmaceuticals Corporation | $190.31 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $182.57 | 2025 | Takhzyro, Cuvitru |
| Regeneron Healthcare Solutions, INC. | $165.38 | 2025 | Dupixent |
| Genzyme Corporation | $147.48 | 2025 | |
| Csl Behring | $146.15 | 2025 | Andembry, Hizentra, Haegarda |
| Biocryst US Sales Co., LLC | $140.50 | 2025 | Orladeyo |
| Glaxosmithkline, LLC. | $101.36 | 2024-2025 | Nucala, Trelegy Ellipta |
| Amgen INC. | $90.64 | 2025 | Tezspire |
| Optinose US, INC. | $85.20 | 2025 | |
| Grifols USA, LLC | $67.25 | 2025 | Xembify |
| Hikma Pharmaceuticals USA | $46.88 | 2025 | Ryaltris |
| Cycle Pharmaceuticals INC | $29.17 | 2025 | Sajazir |
| Ars Pharmaceuticals Operations, INC. | $28.25 | 2025 | Neffy |
| Pharming Healthcare, INC. | $26.29 | 2025 | Ruconest |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $17.58 | 2025 | Xhance |
| Galderma Laboratories, L.P. | $17.03 | 2025 | Nemluvio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nataly Rincon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.